Labcorp Holdings Inc
LH: XNYS (USA)
Morningstar Rating for Stocks | Fair Value | Economic Moat | Capital Allocation |
---|---|---|---|
$619.00 | Sjwxtwc | Fhmbhqdhh |
LabCorp Seeks to Refocus on Diagnostics Once Its Drug Development Segment Is Spun Off
Business Strategy and Outlook
As a leading independent diagnostic laboratory, LabCorp participates in a highly attractive duopoly that offers favorable prospects as healthcare moves toward reformed payment models, like the easing of Medicare headwinds and potentially positive M&A opportunities.